Management of juvenile idiopathic arthritis

Indian Journal of Pediatrics

Volumn 69, Issue 10, 2002, Pages 893-897

  Sawhney, Sujata ^a,b  

^a SIR GANGA RAM HOSPITAL   (India)

^b NONE   (India)

Author keywords

Arthritis; Juvenile; Treatment

Indexed keywords

CELECOXIB; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DICLOFENAC; ETANERCEPT; IBUPROFEN; INDOMETACIN; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; ROFECOXIB; TOLMETIN; TRIAMCINOLONE ACETONIDE;

BLOOD TOXICITY; CHILDHOOD DISEASE; CONFERENCE PAPER; GASTRITIS; HEADACHE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; NEUROTOXICITY; OCCUPATIONAL THERAPY; PATIENT COMPLIANCE; PHYSIOTHERAPY; PROGNOSIS; PSEUDOPORPHYRIA; SKIN ALLERGY; STEM CELL TRANSPLANTATION; TREATMENT INDICATION; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 0036810016     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02723715     Document Type: Conference Paper

References (33)

1. Athreya BH. A general approach to management of children with rheumatic diseases. In Cassidy JT, Petty RE, eds. Textbook of Pediatric Rheumatology. W.B. Saunders; Philadelphia 2001: 190-211.
2. Sherry DD, Mellins ED, Nepom BS, Prieur AM, Laxer RM, Schneider R et al. Arthropathies primarily occuring in childhood. In Maddison PJ, Woo P, Isenberg DA, Glass DN, eds. Oxford Textbook of Rheumatology. 2nd edn. Oxford University Press. New York 1998: 1099-1143
3. Wallace CA. On beyond methotrexate treatment of severe juvenile rheumatoid arthritis. [Review] Clin Exp Rheumatol 1999; 17(4): 499-504.
4. Breit W, Frosch M, Meyer U, Heinecke A, Ganser G. A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis. J Rheumatol 2000; 27(11) : 2696-2702.
5. Sherry DD, Stein LD, Reed. AM, Schanberg LE, Kredich DW. Prevention of leg length discrepancy in young children with pauci-articular juvenile rheumatoid arthritis by treatment with intra articular steroids. Arthritis Rheum 1999; 42: 2330-2334.
6. Petty RE, Cassidy JT. The Juvenile idiopathic arthritides. In Cassidy JT, Petty RE, eds. Textbook of Pediatric Rheumatology. W.B. Saunders; Philadelphia 2001: 214-322.
7. Lovell DJ, Giannini EH, Brewer EJ Jr. Time course of response to nonsteroidal anti inflammatory drugs in juvenile rheumatoid arthritis. Arthritis Rheum 1984; 27: 1433-1437.
8. Giannini EH, Cassidy JT, Brewer EJ, Shaikov A, Maximov A et al. Comparitive efficacy and safety of advanced drug therapy on children with juvenile rheumatoid arthritis. Seminars in Arthritis and Rheumatism 1993; 23: 34-36.
9. Hashkes PJ, Balistreri WF, Bove KE, Ballard ET, Passo MH. The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis. Arthritis Rheum 1997; 12 : 2226-2234.
10. Wallace CA. The use of methotrexate in childhood rheumatic diseases. Arthritis Rheum 1998; 3: 381-391.
11. Rossum MAJ, Fiselier TJ, Franssen JAM, Zwinderman AH, Cate RT, Suijlekom-Smit LWA et al. Sulphasalazine in the treatment of juvenile chronic arthritis. Arthritis Rheum 1998; 41: 808-816.
12. Woo P, Wedderburn LR. Juvenile chronic arthritis. Lancet 1998; 351(9107) 969-973.
13. Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: A potentially fatal complication of rheumatic disorders. Arch Dis Child 2001; 85(5) 421-426.
14. Petty RE, Malleson P. Spondyloarthropathies of childhood. Pediatr Clin North Am 1986; 33(5): 1079-1096.
15. Sawhney S, Woo P. Diagnosis and management of juvenile idiopathic arthritis: Current Status. Indian Pediatr 2001; 38(10): 1083-1089.
16. Weiss AH, Wallace CA, Sherry DD. Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis. [see comments]. J Pediatr 1998; 133(2): 266-268.
17. Wallace CA. Methotrexate: more questions than answers. [Letter; comment]. J Rheumatol 2000; 27(8): 1834-1835.
18. Brooks P. Recent advances: Rheumatology Br Med J 1998. 316(7174) : 1810-1817.
19. Schmeling H, Mathony K, John V, Keysser G, Burdach S, Horneff G. A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study. Ann Rheum Dis 2001; 60(4): 410-2.
20. Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silvermann ED, Nocton JJ et al. Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis. N Engl J Med 2000; 342 : 763-769.
21. Iiowite NT. Current treatment of juvenile rheumatoid arthritis. Pediatrics 2002; 109(1): 109-115.
22. Emery P, Breedveld FC, Lemmel EM, Kaltwasser JP, Dawes PT et al. A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology (Oxford) 2000 ; 39(6) : 655-665.
23. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001; 11; 345(15) : 1098-1104
24. Fleischmann R, Iqbal I, Nandeshwar P, Quiceno A. Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept. Drug Saf 2002; 25(3) : 173-197.
25. Wulffraat N, van Royen A, Bierings M, Vossen J, Kuis W. Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis. Lancet 1999 13; 353 (9152): 550-553.
26. Zak M , Pedersen FK . Juvenile chronic arthritis into adulthood: a long-term follow up study. Rheumatology 2000; 39 : 198-204.
27. Scull SA, Dow MB, Athreya BH. Physical and occupational therapy for children with rheumatic diseases. Pediatr Clin of North Am 1986; 33(5): 1053-1077.
28. Rabinovich CE. Bone mineral status in juvenile rheumatoid arthritis. [Review] J Rheumatol 2000; 27 Suppl 58 : 34-7.
29. Bianchi ML, Cimaz R, Bardare M, Zulian F, Lepore L et al. Efficacy and safety issues of alendronate for the treatment of osteoporosis in diffuse connective diseases in children. Arthritis Rheum 2000; 43(9): 1960-1966.
30. Rooney M, Davies UM, Reeve J, Preece M, Ansell BM, Woo PM. Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis. J Rheumatol 2000; 27(4) : 1073-1081.
31. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997; 40 : 1202-1209.
32. Prieur AM, Chedeville G. Prognostic factors in juvenile idiopathic arthritis. Curr Rheumatol Rep 2001; 3(5) : 371-378.
33. Gare BA, Fasth A. The natural history of juvenile chronic arthritis: A population based cohort study II: Outcome. J Rheumatol 1995; 22 : 308-309